Side-Effect Monitoring for Patients on Depot Antipsychotic Medication Within a Community Treatment Team

Aims To determine whether the community treatment team (CTT) were meeting following three trust standards for patients receiving antipsychotic depot medication: 1. 100% of should have side effects monitored using a validated scoring system in form Glasgow Antipsychotic Side-effect Scale (GASS) once yearly. 2. had GASS completed ever. 3. with this document available full. Additionally adherence to these measures was compared previous year's audit assess change interventions and documentation. Methods A list 146 medication within CTT produced subsequently set up Microsoft excel spreadsheet. Exclusion criteria then applied as follows: any patient no longer under CTT, on antipsychotics admitted hospital at time (to allow comparison year where applied.) Following 127 remained whom I accessed their online notes searched evidence GASS, when if full available. Once data gathered percentage completion calculated each outlined above both overall broken down by administration group. These results audit. Results None met, however notable improvement noted are listed below: In 66% received 53% previously. 97% ever 95% 99% 98% 4. significant variation between groups identified ranging from 17% completion. Conclusion It is clear yearly not being met there intervention suggesting beneficial further been put place including, but limited to, supply spreadsheet date due repeat future tracking improve standards.